-transparent.png){kind=logo}
The drugs used to treat diabetes mellitus are diverse and include several classes. One class is sulfonylureas which primarily cause serum glucose reduction by stimulating the release of preformed insulin from the pancreatic islets. Gliclazide, a second generation sulfonylurea, is used to control glycemic levels in non-insulin-dependent diabetes mellitus. We report a 14 year-old non-diabetic girl who developed hepatitis, hemiplegia and dysphasia after ingestion of an overdose of gliclazide (20 mg/kg/day) in a suicide attempt. Our purpose is to draw attention to the severity of gliclazide-induced neurological signs. To the best of our knowledge, gliclazide-induced hemiplegia and dysphasia have not been previously reported in the literature.
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
May 1998,
Renal failure,
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
October 1985,
Krankenpflege (Frankfurt am Main, Germany),
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
January 2000,
European journal of gastroenterology & hepatology,
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
September 1996,
Annals of emergency medicine,
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
December 2013,
Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences,
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
January 2015,
Kardiologia polska,
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
May 2002,
Digestive diseases and sciences,
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
January 2013,
Revista colombiana de psiquiatria,
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
January 2013,
Revista colombiana de psiquiatria,
H Caksen, and
M Kendirci, and
A Tutuş, and
K Uzüm, and
S Kurtoğlu
December 2021,
Neuropsychopharmacology reports,
